• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素 17β 抑制 MCF-7 细胞中 LKB1 的表达。

LKB1 expression is inhibited by estradiol-17β in MCF-7 cells.

机构信息

Prince Henry's Institute, Block E Level 4, Monash Medical Centre, 246 Clayton Road, Clayton, Melbourne, Victoria 3168, Australia.

出版信息

J Steroid Biochem Mol Biol. 2011 Nov;127(3-5):439-43. doi: 10.1016/j.jsbmb.2011.06.005. Epub 2011 Jun 12.

DOI:10.1016/j.jsbmb.2011.06.005
PMID:21689749
Abstract

The liver kinase B1 (LKB1) is encoded by the STK11 gene and acts as a tumour suppressor and a regulator of energy homeostasis. LKB1 expression is reduced in primary breast tumours compared to normal breast epithelium. Although its expression in primary tumours does not appear to correlate with estrogen receptor (ER) status, it is differentially expressed in breast cancer cell lines where ER-negative cells have lower LKB1 expression than ER-positive cells. The present study aimed to examine the effects of estradiol on LKB1 expression and activity in the ER-positive breast cancer cell line MCF-7. Results demonstrate that estradiol causes a dose-dependent decrease in LKB1 transcript and protein expression and consistent with this, a significant decrease in the phosphorylation of the LKB1 target AMPK (P ≤ 0.05). In order to assess whether effects of estradiol were due to effects on ERα binding to the STK11 promoter, ChIP was performed. Results demonstrate that ERα binds to the STK11 promoter in a ligand-independent manner and that this interaction is decreased in the presence of estradiol. Moreover, STK11 promoter activity is significantly decreased in the presence of estradiol (P ≤ 0.05). LKB1 transcript and IHC score were assessed in primary tumours of 18 patients and demonstrated no significant correlation with ER status (n = 18). Our results thereby provide a mechanism whereby LKB1 is decreased in ER-positive breast tumours.

摘要

肝激酶 B1(LKB1)由 STK11 基因编码,作为一种肿瘤抑制因子和能量平衡的调节剂。与正常乳腺上皮相比,LKB1 在原发性乳腺癌肿瘤中的表达降低。尽管其在原发性肿瘤中的表达似乎与雌激素受体(ER)状态无关,但在乳腺癌细胞系中,ER 阴性细胞的 LKB1 表达低于 ER 阳性细胞,其表达存在差异。本研究旨在研究雌二醇对 ER 阳性乳腺癌细胞系 MCF-7 中 LKB1 表达和活性的影响。结果表明,雌二醇导致 LKB1 转录本和蛋白表达的剂量依赖性降低,与此一致,LKB1 靶标 AMPK 的磷酸化显著降低(P ≤ 0.05)。为了评估雌二醇的作用是否是由于其对 ERα 与 STK11 启动子结合的影响,进行了 ChIP 实验。结果表明,ERα 以配体非依赖性方式与 STK11 启动子结合,而在雌二醇存在下,这种相互作用减少。此外,在雌二醇存在下,STK11 启动子活性显著降低(P ≤ 0.05)。在 18 名患者的原发性肿瘤中评估了 LKB1 转录本和 IHC 评分,与 ER 状态(n = 18)无显著相关性。因此,我们的结果提供了一种机制,即 ER 阳性乳腺癌肿瘤中 LKB1 减少。

相似文献

1
LKB1 expression is inhibited by estradiol-17β in MCF-7 cells.雌激素 17β 抑制 MCF-7 细胞中 LKB1 的表达。
J Steroid Biochem Mol Biol. 2011 Nov;127(3-5):439-43. doi: 10.1016/j.jsbmb.2011.06.005. Epub 2011 Jun 12.
2
Liver kinase B1 expression (LKB1) is repressed by estrogen receptor alpha (ERα) in MCF-7 human breast cancer cells.肝激酶 B1 表达(LKB1)受 MCF-7 人乳腺癌细胞中雌激素受体 α(ERα)的抑制。
Biochem Biophys Res Commun. 2012 Jan 20;417(3):1063-8. doi: 10.1016/j.bbrc.2011.12.096. Epub 2011 Dec 26.
3
Activation of bone morphogenetic protein-6 gene transcription in MCF-7 cells by estrogen.雌激素对MCF-7细胞中骨形态发生蛋白-6基因转录的激活作用。
Chin Med J (Engl). 2005 Oct 5;118(19):1629-36.
4
Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.雌激素受体通向雌激素反应元件的途径:反式激活功能-1作为雌激素受体(ER)β介导的ERα转录抑制的关键要素。
J Steroid Biochem Mol Biol. 2007 May;104(3-5):110-22. doi: 10.1016/j.jsbmb.2007.03.002. Epub 2007 Mar 12.
5
Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.通过雌激素受体α的非基因组作用诱导乳腺癌细胞中芳香化酶(CYP19)的表达。
Cancer Res. 2003 Jul 1;63(13):3546-55.
6
Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.通过雌激素诱导激活结肠和乳腺癌细胞中的ERK 1/2信号通路来调节维生素D受体表达。
J Endocrinol. 2005 Jun;185(3):577-92. doi: 10.1677/joe.1.05770.
7
LKB1 catalytic activity contributes to estrogen receptor alpha signaling.LKB1催化活性有助于雌激素受体α信号传导。
Mol Biol Cell. 2009 Jun;20(11):2785-95. doi: 10.1091/mbc.e08-11-1138. Epub 2009 Apr 15.
8
[Function and prognostic value of tumor suppressor gene LKB1 in human breast carcinoma].肿瘤抑制基因LKB1在人乳腺癌中的功能及预后价值
Zhonghua Yi Xue Za Zhi. 2005 Jan 5;85(1):15-8.
9
The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma.肿瘤抑制基因LKB1与人类乳腺癌的预后相关。
Clin Cancer Res. 2002 Jul;8(7):2085-90.
10
1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.1α,25-二羟基维生素D3下调雌激素受体丰度并抑制MCF-7人乳腺癌细胞中的雌激素作用。
Clin Cancer Res. 2000 Aug;6(8):3371-9.

引用本文的文献

1
C-type lectin-like domain family 2 (CLEC2D) promotes proliferation and migration of breast cancer and serves as a poor prognostic factor.C型凝集素样结构域家族2(CLEC2D)促进乳腺癌的增殖和迁移,并作为一个不良预后因素。
Breast Cancer. 2025 Sep 12. doi: 10.1007/s12282-025-01777-5.
2
Discoidin Domain Receptor 2 (DDR2) Promotes Prostate Cancer Progression in Cooperation with Collagen Remodeling.盘状结构域受体2(DDR2)与胶原蛋白重塑协同促进前列腺癌进展。
Acta Histochem Cytochem. 2025 Aug 28;58(4):143-152. doi: 10.1267/ahc.25-00009. Epub 2025 Jul 17.
3
Discoidin Domain Receptor 2 Contributes to Breast Cancer Progression and Chemoresistance by Interacting with Collagen Type I.
盘状结构域受体2通过与I型胶原蛋白相互作用促进乳腺癌进展和化疗耐药性。
Cancers (Basel). 2024 Dec 23;16(24):4285. doi: 10.3390/cancers16244285.
4
Receptor for Hyaluronan Mediated Motility (RHAMM)/Hyaluronan Axis in Breast Cancer Chemoresistance.乳腺癌化疗耐药中的透明质酸介导的运动受体(RHAMM)/透明质酸轴
Cancers (Basel). 2024 Oct 25;16(21):3600. doi: 10.3390/cancers16213600.
5
Empagliflozin demonstrates cytotoxicity and synergy with tamoxifen in ER-positive breast cancer cells: anti-proliferative and anti-survival effects.恩格列净在雌激素受体阳性乳腺癌细胞中表现出细胞毒性以及与他莫昔芬的协同作用:抗增殖和抗生存效应。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):781-798. doi: 10.1007/s00210-024-03316-z. Epub 2024 Jul 27.
6
Metabolic pathways in obesity-related breast cancer.肥胖相关乳腺癌中的代谢途径。
Nat Rev Endocrinol. 2021 Jun;17(6):350-363. doi: 10.1038/s41574-021-00487-0. Epub 2021 Apr 29.
7
Transcriptomic profiling of PBDE-exposed HepaRG cells unveils critical lncRNA- PCG pairs involved in intermediary metabolism.经 PBDE 暴露的 HepaRG 细胞转录组谱分析揭示了参与中间代谢的关键长非编码 RNA-PCG 对。
PLoS One. 2020 Feb 26;15(2):e0224644. doi: 10.1371/journal.pone.0224644. eCollection 2020.
8
Differentially Expressed Mitochondrial Proteins in Human MCF7 Breast Cancer Cells Resistant to Paclitaxel.紫杉醇耐药的人 MCF7 乳腺癌细胞中差异表达的线粒体蛋白。
Int J Mol Sci. 2019 Jun 19;20(12):2986. doi: 10.3390/ijms20122986.
9
Expression of gene and its promoter activity in MCF control and cancer cells.基因在MCF对照细胞和癌细胞中的表达及其启动子活性。
3 Biotech. 2017 Dec;7(6):362. doi: 10.1007/s13205-017-1000-6. Epub 2017 Oct 4.
10
AMP-activated protein kinase and energy balance in breast cancer.AMP激活的蛋白激酶与乳腺癌中的能量平衡
Am J Transl Res. 2017 Feb 15;9(2):197-213. eCollection 2017.